salesforce.com inc. [CRM] Insider Just Sold 5,000 Shares. Should You?
On Jan. 07, Tallapragada Srinivas divested U.S. $1,082,500 in shares of salesforce.com inc.. The Pres, Chief Engineering Office sold 5,000 shares at a price per share of $216.50. The transaction decreased this specific insider’s holdings to 45,809 shares worth around $9.99 million at present. Meanwhile, Citigroup had lowered its rating on CRM to “Neutral” from […]
SVB Leerink maintains Accolade [ACCD]’s rating to Market Perform and price target at $53.0
SVB Leerink maintained its Accolade [ACCD] rating to the equivalent of Market Perform but changed the price target to $53.0 from $53, in a research note dated 2021-01-08. That figure represents around a 12.96% premium from where the company’s shares closed on Thursday. Some new analysts also started their coverage, with Canaccord Genuity’s analysts assigning […]
A-Mark Precious Metals Inc. [AMRK] Sees 20,000 Share Insider Sell From Pres Gjerdrum Thor
On Jan. 05, Gjerdrum Thor divested U.S. $537,900 in shares of A-Mark Precious Metals Inc.. The Pres sold 20,000 shares at a price per share of $26.89. The transaction decreased this specific insider’s holdings to 0 shares worth around $0.0 at present. ROTH Capital launched its A-Mark Precious Metals Inc. [AMRK] rating to the equivalent […]
Needham maintains Revance Therapeutics [RVNC] at Buy rating with a $45 price target
Needham maintained its Revance Therapeutics [RVNC] rating to the equivalent of Buy but changed the price target to $45.0 from $42, in a research note dated 2021-01-08. That figure represents around a 52.08% premium from where the company’s shares closed on Thursday. Meanwhile, Goldman had lowered its rating on RVNC to “Neutral” from the earlier […]
Insider Alert: Novavax Inc. [NVAX]’s EVP, CMO, CBO, Trizzino John, Makes A $2,012,353 Sell
On Jan. 05, Trizzino John divested U.S. $2,012,353 in shares of Novavax Inc.. The EVP, CMO, CBO sold 17,913 shares at a price per share of $112.34. The transaction decreased this specific insider’s holdings to 287 shares worth around $36787.66 at present. Jefferies launched its Novavax Inc. [NVAX] rating to the equivalent of a Buy […]
HC Wainwright & Co. maintains Krystal Biotech [KRYS] at Buy rating with a $84 price target
HC Wainwright & Co. maintained its Krystal Biotech [KRYS] rating to the equivalent of Buy but changed the price target to $84.0 from $68, in a research note dated 2021-01-08. That figure represents around a 28.74% premium from where the company’s shares closed on Thursday. Some new analysts also started their coverage, with Evercore ISI’s […]
Insider Selling: iRhythm Technologies Inc. [IRTC] EVP, Sales Sells 5,000 Shares Worth $1,140,431
On Jan. 05, Vort David A divested U.S. $1,140,431 in shares of iRhythm Technologies Inc.. The EVP, Sales sold 5,000 shares at a price per share of $228.09. The transaction decreased this specific insider’s holdings to 15,602 shares worth around $3.43 million at present. Oppenheimer took its iRhythm Technologies Inc. [IRTC] rating to the equivalent […]
Endeavour Silver [EXK] gets its Buy rating reiterated by HC Wainwright & Co.
HC Wainwright & Co. maintained its Endeavour Silver [EXK] rating to the equivalent of Buy but changed the price target to $6.75 from $5.75, in a research note dated 2021-01-08. That figure represents around a 25.29% premium from where the company’s shares closed on Thursday. Some new analysts also started their coverage, with B. Riley […]
Insider Selling Report: Colfax Corporation [CFX]’s Pres, CEO, Trerotola Matthew L., Sells 22,039 Shares
On Jan. 05, Trerotola Matthew L. divested U.S. $840,181 in shares of Colfax Corporation. The Pres, CEO sold 22,039 shares at a price per share of $38.12. The transaction decreased this specific insider’s holdings to 200,967 shares worth around $8.16 million at present. UBS took its Colfax Corporation [CFX] rating to the equivalent of a […]
F5 Networks [FFIV] gets its Buy rating reiterated by Needham
Needham maintained its F5 Networks [FFIV] rating to the equivalent of Buy but changed the price target to $235.0 from $210, in a research note dated 2021-01-08. That figure represents around a 30.48% premium from where the company’s shares closed on Thursday. Other analysts also revised their coverage, with Colliers Securities’s analysts reiterating the shares […]
